Victor Kandasamy

Démarches visant à vérifier et obtenir le financement nécessaire provenant de divers ministères et agences, afin de soutenir le fonctionnement de Technologies Luqia, incluant son programme de recherche interne, la valorisation de ses technologies, ses infrastuctures et ses équipements.

Démarches afin de faire connaître la valeur ajoutée de Kiewit, présent au Québec depuis plus de 60 ans, ainsi que son expertise en réalisation de projets selon des approches contractuelles alternatives dont la conception-construction progressive, la réalisation de projet intégrée et l'alliance. - Assurer une concurrence efficace dans les contrats publics, ou soutenus par des investissements publics, à l'égard de tous les fournisseurs

Promotion de l'avancement de la cybersécurité dans les transports publiques. Advocating for the rail sector in relation to changes to clean technology investment tax credit. Recherche de financement via le programme de fonds stratégiques pour l'innovation (FSI) afin d'offrir des solutions ferroviaires innovantes. Establishment or modification of appropriate regulations regarding trade. Research and Development funding for advanced manufacturing and developing mobility low to zero carbon technologies. Infrastructure projects related to transit systems, including rolling stocks and signalling. Establishment or modification of appropriate regulations regarding public transportation.

Régime canadien de soins dentaires Discussion avec des titulaires de charges publiques concernant le Régime canadien de soins dentaires (RCSD) en lien avec son implantation et ses impacts sur les cliniques dentaires du Québec.

Meeting with elected and non-elected officials to discuss the Association's priority issues. Meetings with elected and non-elected officials to discuss the federal government's dental care program.

Représenter Micrologic auprès des cabinets politiques et hauts-fonctionnaires en vue de les informer et influencer les politiques et les programmes sur l'enjeu de la souveraineté numérique.

Étude du Comité permanent de l’industrie et de la technologie visant à examiner la mise en place d’une stratégie industrielle de défense pour renforcer l’autonomie du Canada en matière de défense et de sécurité nationales. Dépôt d'un mémoire Micrologic souhaite contribuer à la réflexion gouvernemental sur le cloud souverain et la cybersécurité. Il souhaite également être considéré pour des contrats d'hébergement de données - Marché public

Engage with government to strengthen the Priority Review of Drug Submissions process. The Government of Ontario has passed legislation requiring the public disclosure of payments made to Health Care Providers and Health Care Organizations by the broader health care industry, including pharmaceutical companies, generic manufacturers, and medical device companies. GlaxoSmithKline seeks to advocate for a national approach to disclosure through either the support of similar provincial initiatives, coordinated action through the Federal / Provincial and Territorial meetings of the Ministers of Health, and / or the establishment of national requirements. Sharing information with government and Members of Parliament on different models for national pharmacare, specifically as it relates to access to medicines. Renewal of national vaccine strategy to close gaps in vaccination coverage for Canadians, especially among seniors. Reforms to the Patented Medicines Review Board (PMPRB), whose guidelines seek to ensure a balance between the prices set by manufacturers for patented medicines sold in Canada and the maintenance of an attractive environment for pharmaceutical research and development. Specifically with regard to ensuring that any actions and proposed changes by the PMPRB do not negatively impact access to patented medicines in Canada. Raise awareness regarding the potential risks to drug and vaccine supply for Canadian patients arising from new U.S. state-level reimportation legislation. Participation in consultations regarding the Digital Charter and the federal government's plans to overhaul Canada's privacy regime, to enable the use of anonymized health data for new medication research and development. Input on the work of the Advisory Committee on the Implementation of National Pharmacare, specifically as it relates to access to medicines. Harmonizing rules for the sampling of natural health products under the proposed Canada-United States-Mexico trade agreement. Ensure the National Advisory Committee on Immunization has sufficient resources to undertake timely reviews of new vaccines that are made available to the Canadian marketplace. Engaging Health Canada on the Self-Care Products Initiative as it pertains to plain language labelling and a risk-based approach to regulatory oversight for non prescription drugs. Engage the government regarding the need for clear and efficient procurement processes for COVID-19 medical countermeasures, including COVID-19 therapeutics, to ensure access for Canadians. Engagement with government officials on disruptions to business, health & safety requirements, and opportunities to help with the COVID-19 pandemic. Engage government officials regarding domestic manufacturing of seasonal and pandemic flu vaccine. Antimicrobial Resistance (AMR) - Identification of the need for a multi-sectoral stakeholder working group to pursue joint goals under a Pan-Canadian AMR strategy and to strengthen Canada's end-to-end research capacity in AMR. Allow for the regulation of products containing cannabidiol (CBD) as natural health products.

Engagement with the Government regarding the Life Science Fund seeking partnership and funding to support completion of Phase I and Phase II clinical research program associated to AMR (antimicrobial resistance) Antimicrobial Resistance (AMR) - Seek funding and support for pilot projects making anti-infective medications available to equity seeking populations, helping to combat AMR. Also discuss any applicable conditions regarding this funding. Programs and policy to support Canadian biomanufacturing and access to medicines and vaccines for Canadians. National Immunization Strategy and policies and programs that impact public access to vaccines and disease prevention in Canada. Patented Medicines Review Board (PMPRB), certified under the Patent Act and whose guidelines seek to ensure a balance between the prices set by manufacturers for patented medicines sold in Canada and the maintenance of an attractive environment for pharmaceutical research and development. Engagement with federal officials regarding the Biomanufacturing & Life Sciences Strategy and policies and programming related to biomanufacturing in Canada Access to medicines - government policies, processes, legislation, and/or regulation with potential impact on access to medicines in Canada. Trade-related matters, including policies and tariffs impacting medicines and vaccines. Policies and programs related to the health of new immigrants to Canada. Policies, programs, and funding related to Canada's Sexually Transmitted and Blood-Borne Infections (STBBI) Action Plan 2024-2030. Engagement with federal officials regarding Health Emergency Readiness Canada. The National Pharmaceutical Strategy (NPS) as agreed by First Ministers in 2004. Advocacy for ways to increase access to medicines and vaccines for Canadian patients. The Common Drug Review (CDR) process for reviewing new drugs and providing listing recommendations to publicly funded drug benefit plans in Canada. Ensuring the access needs of Canadian patients are met by advocating on activities undertaken in the context of the CDR. Science and Technology (S&T) Strategy: Mobilizing Science and Technology to Canada's Advantage. Advocacy for measures which will allow for commercialization in health care to occur and for Canada to remain competitive internationally on Intellectual Property and other fronts. Public Services and Procurement Canada (PSPC) Integrity Framework - Clarifying the process for procurement of vaccines and possibly pharmaceuticals under the evolving procurement framework. Patented Medicines (Notice of Compliance) Regulations which seek to balance the protection of Intellectual Property (IP) and patents with cost containment. Advocacy to ensure that IP rights are respected and internationally competitive in order to promote Research and Development. Legislation, regulations, policies and programs concerning the federal government's response to COVID-19, including pandemic preparedness, pharmaceutical and vaccine supply-chain management, and general administration of justice. Food and Drugs Act and the bill formerly known as Bill C-51: An Act to amend the Food and Drugs Act and to make consequential amendments to other Acts. Specifically, with respect to the renewal of the drug approval process. Advocacy to ensure that Canada's review and approval process is timely, safe, effective, competitive and consistent with other jurisdictions. FedDev Ontario Advanced Manufacturing Fund - advancing manufacturing of innovative pharmaceutical products in southern Ontario Engage with government to strengthen the Priority Review for Drug Submissions process. Engage the Government regarding the need for clear and efficient procurement processes for COVID-19 medical countermeasures, including COVID-19 therapeutics, to ensure access for Canadians. Engagement with the Government regarding the Strategic Innovation Fund Drug Re-importation - Raise awareness regarding the potential risks to drug and vaccine supply fo

Discussions avec le gouvernement fédéral en ce qui concerne le financement en recherche et en innovation Discussions avec le gouvernement fédéral en ce qui concerne les programmes en immigration Favoriser des collaborations entre l'Université Laval et des partenaires pour accélérer l'innovation. Doter l'Université Laval des ressources nécessaires pour réaliser ces collaborations.

Meetings with elected and non-elected officials regarding measures to Strengthen Canadian Competitiveness and Economic Sovereignty for the furniture industry in Canada. Meetings with elected and non-elected officials regarding the federal government prioritization of Canadian furniture in their calls for tenders, the implementation of clear and strict criteria within the "Buy Canadian" policy to support local industries and the establishment monitoring mechanisms to ensure compliance with procurement guidelines. Meetings with elected and non-elected officials regarding dumping practices and the implementation of regulatory mechanisms adapted to limit market distortions. Meetings with elected and non-elected officials regarding the potential implementation of the United States tariffs and the negotiations on the 2026 United States, Mexico and Canada Trade Agreement. Meetings with elected and non-elected officials regarding the potential application of United States tariffs on the goods of the furniture industry. Meetings with elected and non-elected officials regarding the impact of temporary foreign workers on the furniture industry.

Recherche de financement et un soutien du gouvernement fédéral accru pour assurer la réussite et la pérennité du Programme?national d’alimentation scolaire universel. Collaborer avec les différents paliers de gouvernement, le secteur privé et les organisations communautaires pour établir un modèle de partage des coûts durable qui soutient en priorité les enfants et les milieux qui font face à des obstacles à une alimentation saine. "L’organisme défend et participe à la mise en œuvre des lois, politiques et programmes de financement pour instaurer un Programme?national d’alimentation scolaire universel, pérenne, et renforçant les liens avec les systèmes alimentaires locaux. La vision du Club des petits?déjeuners est celle d’un pays où tous les enfants ont accès chaque jour à des aliments nutritifs à l’école. Pour réaliser cette vision, l’organisme défend et participe à la mise en œuvre des lois, politiques et programmes de financement pour instaurer un Programme?national d’alimentation scolaire universel, pérenne, et renforçant les liens avec les systèmes alimentaires locaux. Il collabore avec les différents paliers de gouvernement, le secteur privé et les organisations communautaires pour établir un modèle de partage des coûts durable qui soutient en priorité les enfants et les milieux qui font face à des obstacles à une alimentation saine. Un financement et un soutien du gouvernement fédéral accru sont indispensables pour assurer la réussite et la pérennité de ce programme.

Urging the federal government to lead the development of and work with the provinces and territories to implement a pan-Canadian digital health strategy. That the minister of health create a public awareness campaign to bring attention to the scourge of counterfeit prescription drugs That the federal government lead efforts to educate health-care workers on the importance of medication safety and deprescribing Support for regulated nurses working at full scope of practice Strengthening of programs and supports for vulnerable populations, including child health, senior's health and domestic maternal, newborn and child health strategy development. Strengthening and creating programs to support illness prevention and health promotion, long term care, palliative care, home and community care, affordable housing and other social determinants of health Strategies to address the health human resources crisis and nursing shortages across Canada, including providing funding to provinces and territories to help optimize workloads; financial supports for nurses and health-care workers such as loan forgiveness, tax incentives, retention bonuses for senior nurses; creating a mental health action plan for health-care workers; increasing training and education for health-care workers. Seeking funding for the Nursing the Future initiative Seek funding for nursing research Review the Income Tax Act, List of Authorized Medical Practitioners to ensure all categories of nurses are easily identified. Requesting the federal government to create a one-time fund of $1.2 billion over four years via the Primary Care Transition Fund II to expand the establishment of primary care teams in each province and territory, with a special focus in remote and underserved communities. Reinstate the position of a Chief Nursing Officer at the federal level, and support for CNO's in all provinces and territories. Provide funding for a comprehensive, universal, public, affordable prescription medication coverage that ensures access in all health-care settings based on need and not the ability to pay Protection of public from the ongoing and growing threat of antimicrobial resistance Pandemic Planning and COVID-19: ensure all nurses are properly supported and protecting by ensuring appropriate stockpiling of PPE, support for mental health while on the front lines, support for nursing students, increased access to education and training when return to work or working in various care setting while responding to a pandemic, ensuring appropriate guidelines and resources are disseminated and developed and ensure senior nurses are part of discussions and advisory review boards during pandemics in planning phases as well as post pandemic in the review. Nursing-entry to practice Invest in strategies to prevent and mitigate the health effects of climate change Influencing the Canada Health Transfer and Health Bilateral Agreements between the federal government and provinces and territories to urge governments to increase healthcare investments and invest in priority areas such as the health workforce, primary care, long-term care, mental health, data and virtual care, and surgeries and backlogs. Increasing federal health transfers to the provinces and territories via a demographic top-up to meet the needs of Canada's aging population. Increase support to Canadians who provide care for aging relatives and friends. Incorporate Primary Health Care (PHP) principles within a Health in All Policies approach Improving care in long-term care facilities through enhanced access to and provision of care from regulated nurses. Improve community- and home-based health promotion Improve access to primary care, home care, and palliative and end-of-life care for all people in Canada. Funding to support nursing certification across Canada to strengthen the safe delivery of expert care to older adults. Funding to support newly graduated nurses moving into professional practice for the first tim